STOP2030 at the Annual NTD Programme Manager Meeting: STH innovation in focus
Several members of the STOP2030 consortium participated in the 2026 [...]
Ghana FDA approves the fixed-dose coformulation of ivermectin and albendazole
In the last days of December 2025, the Ghana Food [...]
The REALISE clinical begins sample collection and dosing
Our latest clinical trial has started its clinical phase as sample collection and dosing started in Kenya
Meta-analysis shows age-based fixed ivermectin dosing could transform MDA campaigns
Ivermectin, one of the two medicines used in our fixed-dose [...]
With the Site Initiation Visit Complete, Our Team Prepares to Launch the REALISE Study
The Ghana Health Service (GHS) Research and Development Division, along [...]
EMA adopts positive scientific opinion on our ivermectin/albendazole fixed-dose coformulation
The STOP2030 Consortium is pleased to announce that the Committee [...]
STOP2030 team at InCORNTD 2025
Colleagues from the STOP2030 consortium attended last week the [...]
Our FDC of albendazole & ivermectin demonstrates safety and superior efficacy in phase 2-3 trial
Researchers from African, Latin American and European organisations have published [...]
WHO Publishes the First Guidelines for Controlling Strongyloides stercoralis
Controlling Strongyloides stercoralis: WHO's recommendations for addressing it as a [...]
Our latest popPK study supports the dosing strategy of our ivermectin/albendazole FDC
A new paper on the population pharmacokinetics (PK) of our [...]
